See more : Bionoid Pharma Inc. (BINP) Income Statement Analysis – Financial Results
Complete financial analysis of Dazed, Inc. (MEDH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dazed, Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
You may be interested
- RELX PLC (REN.AS) Income Statement Analysis – Financial Results
- TY Holdings Co., Ltd (363280.KS) Income Statement Analysis – Financial Results
- Astro Malaysia Holdings Berhad (6399.KL) Income Statement Analysis – Financial Results
- Jardine Cycle & Carriage Limited (JCYGY) Income Statement Analysis – Financial Results
- Hyundai Bng Steel Co., Ltd. (004560.KS) Income Statement Analysis – Financial Results
Dazed, Inc. (MEDH)
About Dazed, Inc.
Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 1.48M | 2.18M | 724.82K | 0.00 | 0.00 | 752.15K | 83.68K | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 7.50K | 659.27K | 549.03K | 239.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | -7.50K | 821.46K | 1.63M | 484.93K | 0.00 | 0.00 | 752.15K | 83.68K | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 55.48% | 74.77% | 66.90% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 261.81 | 57.09 | 0.00 | 0.00 | 5.97M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 711.55K | 57.03K | 0.00 | 0.00 | 5.26M | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 54.49K | 513.58K | 711.81K | 57.09K | 177.95K | 290.75 | 11.23M | 8.07M | 16.99K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 54.49K | 513.58K | 711.81K | 57.09K | 177.95K | 290.75 | 11.23M | 8.07M | 16.99K |
| Cost & Expenses | 0.00 | 0.00 | 61.99K | 1.17M | 1.26M | 296.98K | 177.95K | 290.75 | 11.23M | 8.07M | 16.99K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 1.78 | 0.00 | 0.00 | 138.00K | 86.97K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 105.27K | 1.78K | 0.00 | 0.00 | 844.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 7.50K | 12.10K | 12.20K | -427.84 | 0.00 | 0.00 | 20.74K | 4.56K | -33.97K |
| EBITDA | 0.00 | 0.00 | -2.62M | -796.36K | 927.29K | 427.84K | -177.95K | -290.00 | -10.46M | -7.98M | -16.99K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 21.61% | 42.62% | 59.03% | 0.00% | 0.00% | -1,327.30% | -9,476.81% | 0.00% |
| Operating Income | 0.00 | 0.00 | -61.99K | 307.88K | 915.09K | 427.84K | -177.95K | -290.00 | 10.48M | 7.99M | 16.99K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 20.79% | 42.06% | 59.03% | 0.00% | 0.00% | 1,393.04% | 9,542.83% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | -2.68M | -1.12M | -18.54K | -1.78K | -146.75K | -0.75 | -335.79K | 36.28K | 0.00 |
| Income Before Tax | 0.00 | 0.00 | -2.74M | -810.25K | 896.56K | 426.06K | -324.70K | -290.75 | 10.00M | 7.93M | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | -54.72% | 41.20% | 58.78% | 0.00% | 0.00% | 1,330.05% | 9,482.25% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | -4.00 | 2.00 | 427.84 | 0.00 | 0.00 | 335.79K | -36.28K | 33.97K |
| Net Income | 0.00 | 0.00 | -2.74M | -810.25K | 896.56K | 426.06K | -324.70K | -290.75 | -10.81M | -7.95M | -16.99K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | -54.72% | 41.20% | 58.78% | 0.00% | 0.00% | -1,437.69% | -9,499.47% | 0.00% |
| EPS | 0.00 | 0.00 | -0.03 | -0.01 | 0.01 | 0.00 | -0.01 | 0.00 | -63.10 | -69.25 | -0.20 |
| EPS Diluted | 0.00 | 0.00 | -0.03 | -0.01 | 0.01 | 0.00 | -0.01 | 0.00 | -63.10 | -69.25 | -0.20 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 98.50M | 93.56M | 115.98M | 112.61M | 28.07M | 25.37M | 171.36K | 114.79K | 85.00K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 98.50M | 93.56M | 115.98M | 112.61M | 61.81M | 73.57M | 171.36K | 114.79K | 85.00K |
MedX Holdings, Inc. Announces OTC “Current” Status
Cheyenne, Wyoming, November 3, 2020 – OTC PR WIRE – MedX Holdings Inc. (OTC PINK: MEDH), announced today that the Company has achieved OTC CURRENT status with OTC Markets.
Source: https://incomestatements.info
Category: Stock Reports